Valuation: Celltrion, Inc.

Capitalization 38,118B 26.25B 25.37B 23.95B 21.13B 37.56B 2,278B 41.69B 285B 106B 946B 98.38B 96.43B 3,997B P/E ratio 2024 *
91.8x
P/E ratio 2025 * 34.2x
Enterprise value 39.24B 27.02M 26.12M 24.66M 21.75M 38.66M 2.34B 42.92M 294M 109M 974M 101M 99.26M 4.11B EV / Sales 2024 *
11.2x
EV / Sales 2025 * 8.82x
Free-Float
70.89%
Yield 2024 *
0.27%
Yield 2025 * 0.27%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.39%
1 week+2.10%
1 month-2.92%
3 months+3.96%
6 months-3.73%
Current year-4.16%
More quotes
1 week
175 800.00
Extreme 175800
181 700.00
1 month
172 800.00
Extreme 172800
187 800.00
Current year
172 800.00
Extreme 172800
188 300.00
1 year
152 666.67
Extreme 152666.6667
200 952.38
3 years
124 761.90
Extreme 124761.9048
229 523.81
5 years
121 906.48
Extreme 121906.48
355 157.15
10 years
35 797.63
Extreme 35797.6274
355 157.15
More quotes
Director TitleAgeSince
Chief Executive Officer - 19/03/2015
Director of Finance/CFO 50 -
Compliance Officer 43 -
Manager TitleAgeSince
Chairman 67 -
Director/Board Member 66 16/07/2008
Director/Board Member 66 16/07/2008
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
+0.39%+2.10%+5.06%+22.26% 26.18B
+0.59%+0.46%+36.26%-0.85% 48.01B
-2.64%+0.97%-7.30%-17.32% 36.45B
-1.09%-2.43%-32.18%-27.91% 15.76B
+2.66%+1.07%+65.18%+75.47% 15.43B
-2.76%-9.10%-65.10%-80.75% 12.26B
-2.32%-5.72%-2.22%-34.64% 11.05B
-7.01%-5.20%+1.46%+88.07% 10.99B
+2.08%+15.74% - - 10.76B
-1.40%-8.72%-12.18%-22.99% 8.66B
Average -1.08%-0.62%-1.23%+0.15% 19.56B
Weighted average by Cap. -0.71%+0.38%+6.46%+0.17%
See all sector performances

Financials

2024 *2025 *
Net sales 3,496B 2.41B 2.33B 2.2B 1.94B 3.44B 209B 3.82B 26.16B 9.71B 86.81B 9.02B 8.84B 367B 4,426B 3.05B 2.95B 2.78B 2.45B 4.36B 265B 4.84B 33.12B 12.29B 110B 11.42B 11.2B 464B
Net income 446B 307M 297M 280M 247M 439M 26.65B 488M 3.34B 1.24B 11.07B 1.15B 1.13B 46.76B 1,175B 810M 782M 739M 652M 1.16B 70.25B 1.29B 8.79B 3.26B 29.19B 3.03B 2.97B 123B
Net Debt 1,118B 770M 744M 703M 620M 1.1B 66.82B 1.22B 8.36B 3.1B 27.76B 2.89B 2.83B 117B 926B 638M 616M 582M 513M 912M 55.33B 1.01B 6.93B 2.57B 22.99B 2.39B 2.34B 97.08B
More financial data * Estimated data
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,391
More about the company
Date Price Change Volume
10/02/25 179,700.00 +0.39% 412,480
10/02/25 179,000.00 -0.33% 494,889
07/02/25 179,600.00 -0.77% 306,726
06/02/25 181,000.00 +1.51% 390,088
05/02/25 178,300.00 +0.51% 387,834

End-of-day quote Korea S.E., February 10, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
179,700.00KRW
Average target price
235,952.38KRW
Spread / Average Target
+31.30%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock